Open AccessIbrutinib + Cirmtuzumab in Patients With CLL/SLL or Mantle Cell Lymphoma
Author(s) -
Richard Simoneaux
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000658712.96226.34
Subject(s) - mantle cell lymphoma , ibrutinib , chronic lymphocytic leukemia , medicine , cancer research , lymphoma , bruton's tyrosine kinase , oncology , tyrosine kinase , leukemia , receptor